•
Dec 31, 2019

Albemarle Q4 2019 Earnings Report

Albemarle's Q4 2019 results were announced, showcasing an increase in net sales and adjusted EPS, but a decrease in diluted EPS due to specific factors.

Key Takeaways

Albemarle Corporation reported an increase in net sales and adjusted diluted EPS for Q4 2019, but diluted EPS decreased. The company completed the acquisition of a 60% ownership in the Wodgina spodumene mine and formed a joint venture. They also issued notes to repay debt and fund the acquisition.

Net sales increased by ~8%, driven by volume in Lithium and Fine Chemistry Services and pricing in Bromine Specialties and Catalysts.

Diluted EPS decreased by ~30%, while adjusted diluted EPS increased by ~13%.

Adjusted EBITDA increased by ~12%.

Completed acquisition of 60% ownership in the Wodgina spodumene mine.

Total Revenue
$993M
Previous year: $922M
+7.7%
EPS
$1.73
Previous year: $1.53
+13.1%
Adjusted EBITDA
$295M
Previous year: $264M
+11.5%
Gross Profit
$339M
Previous year: $320M
+5.7%
Cash and Equivalents
$613M
Previous year: $555M
+10.4%
Free Cash Flow
$130M
Previous year: -$59.1M
-320.7%
Total Assets
$9.86B
Previous year: $7.58B
+30.1%

Albemarle

Albemarle

Albemarle Revenue by Segment

Forward Guidance

Albemarle anticipates its 2020 performance to be lower year-over-year based on expected lower results from Lithium and flat-to-slightly lower results from Bromine Specialties, partially offset by flat to slightly higher results from Catalysts.

Revenue & Expenses

Visualization of income flow from segment revenue to net income